{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T03:05:15Z","timestamp":1761102315025,"version":"build-2065373602"},"reference-count":14,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["journals.elsevierhealth.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Nuclear Cardiology"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1007\/s12350-018-1362-0","type":"journal-article","created":{"date-parts":[[2018,7,27]],"date-time":"2018-07-27T13:03:55Z","timestamp":1532696635000},"page":"225-227","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Tc-99m pyrophosphate imaging for transthyretin cardiac amyloidosis: Importance of estimation of cancer risk with the modality"],"prefix":"10.1016","volume":"27","author":[{"given":"Shivda","family":"Pandey","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omar K.","family":"Siddiqi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1007\/s12350-018-1362-0_bib1","first-page":"113","article-title":"Left ventricular amyloid deposition in patients with heart failure and preserved ejection fraction","volume":"2","author":"Mohammed","year":"2014","journal-title":"J Am Coll Cardiol HF"},{"key":"10.1007\/s12350-018-1362-0_bib2","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1093\/eurheartj\/ehv338","article-title":"Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction","volume":"36","author":"Gonz\u00e1lez-L\u00f3pez","year":"2015","journal-title":"Eur Heart J."},{"issue":"5","key":"10.1007\/s12350-018-1362-0_bib3","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.ahj.2010.02.006","article-title":"Significance of the amyloidogenic transthyretin Val 122 ile allele in african Americans in the arteriosclerosis risk in communities (ARIC) and cardiovascular health (CHS) studies","volume":"159","author":"Buxbaum","year":"2010","journal-title":"Am Heart J"},{"key":"10.1007\/s12350-018-1362-0_bib4","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1080\/13506129.2017.1391086","article-title":"Prevalence of mutant ATTR cardiac amyloidosis in elderly African Americans with heart failure","volume":"24","author":"Arvanitis","year":"2017","journal-title":"Amyloid."},{"key":"10.1007\/s12350-018-1362-0_bib5","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.jcin.2012.03.012","article-title":"Pathology of transcatheter valve therapy","volume":"5","author":"Nietlispach","year":"2012","journal-title":"J Am Coll Cardiol Intv"},{"key":"10.1007\/s12350-018-1362-0_bib6","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.116.005066","article-title":"Occult transthyretin cardiac amyloid in severe calcific aortic stenosis: Prevalence and prognosis in patients undergoing surgical aortic valve replacement","volume":"9","author":"Treibel","year":"2016","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1007\/s12350-018-1362-0_bib7","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1093\/eurheartj\/ehx350","article-title":"Unveiling transthyretin cardiac amyloidosis and its predictors among elderly patients with severe aortic stenosis undergoing transcatheter aortic valve replacement","volume":"38","author":"Casta\u00f1o","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1007\/s12350-018-1362-0_bib8","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1161\/CIRCIMAGING.112.000132","article-title":"99mTc-pyrophosphate scintigraphy for differentiating light-chain cardiac amyloidosis from the transthyretin-related familial and senile cardiac amyloidoses","volume":"6","author":"Bokhari","year":"2013","journal-title":"Circ Cardiovasc Imaging."},{"key":"10.1007\/s12350-018-1362-0_bib9","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.tcm.2017.07.004","article-title":"Cardiac amyloidosis: An update on pathophysiology, diagnosis, and treatment","volume":"28","author":"Siddiqi","year":"2018","journal-title":"Trends Cardiovasc Med."},{"issue":"4","key":"10.1007\/s12350-018-1362-0_bib10","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.117.004769","article-title":"TTR (Transthyretin) Stabilizers Are Associated With Improved Survival in Patients With TTR Cardiac Amyloidosis","volume":"11","author":"Rosenblum","year":"2018","journal-title":"Circ Heart Fail."},{"key":"10.1007\/s12350-018-1362-0_bib11","first-page":"1117","article-title":"Imaging Agents","volume":"30","author":"Weber","year":"1989","journal-title":"J Nucl Med."},{"key":"10.1007\/s12350-018-1362-0_bib12","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1177\/0146645314558019","article-title":"Radiation dose to patients from radiopharmaceuticals: A compendium of current information related to frequently used substances","volume":"44","author":"Mattsson","year":"2015","journal-title":"Ann ICRP"},{"key":"10.1007\/s12350-018-1362-0_bib13","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1088\/0952-4746\/32\/3\/205","article-title":"RadRAT: a radiation risk assessment tool for lifetime cancer risk projection","volume":"32","author":"Berrington de Gonzalez","year":"2012","journal-title":"J Radiol Prot"},{"key":"10.1007\/s12350-018-1362-0_bib14","article-title":"Variability in radiation dose estimates from nuclear and computed tomography diagnostic imaging","author":"Ep","year":"2009","journal-title":"JNC"}],"container-title":["Journal of Nuclear Cardiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12350-018-1362-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12350-018-1362-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071358123017580?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071358123017580?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12350-018-1362-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T06:07:30Z","timestamp":1761026850000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1071358123017580"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":14,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["S1071358123017580"],"URL":"https:\/\/doi.org\/10.1007\/s12350-018-1362-0","relation":{},"ISSN":["1071-3581"],"issn-type":[{"type":"print","value":"1071-3581"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tc-99m pyrophosphate imaging for transthyretin cardiac amyloidosis: Importance of estimation of cancer risk with the modality","name":"articletitle","label":"Article Title"},{"value":"Journal of Nuclear Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s12350-018-1362-0","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2020 American Society of Nuclear Cardiology. Published by ELSEVIER INC. All rights reserved. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}